Abstract
Autoimmune sensorineural hearing loss (ASNHL) is typically presented by a bilateral rapidly progressive hearing loss that may also occur suddenly. Both autoantibodies and autoreactive T cells have been implicated in the etiopathogenesis of ASNHL. However, the identity of a specific or highly relevant inner-ear self-antigen is still required. A definite diagnosis of ASNHL is usually made by excluding ototoxicity, and other factors that mimic ASNHL but most importantly by demonstrating a good therapeutic response to corticosteroid treatment.
In this chapter, we will summarize many of the current studies that have established the idea of ASNHL being autoimmune in many cases. Also, we will address the need for specific diagnostic tools to better classify/diagnose this entity. These tools may lead to the development and application of immuosuppressive therapies to prevent the deterioration of hearing loss and could possibly prevent the requirement for cochlear implantation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
McCabe BF. Autoimmune sesorineural hearing loss. Ann Otol Rhinol Laryngol 1979; 88: 585–89.
Solares CA, Hughes GB, Tuohy VK. Autoimmune sensorineural hearing loss: An immunologic perspective. J Neuroimmunol 2003; 138: 1–7.
Suzuki M, Krug MS, Cheng KC, Yazawa Y, Bernstein J, Yoo TJ. Antibodies against inner-ear proteins, in the sera of patients with inner-ear diseases. ORL J Otorhinolaryngol Relat Spec 1997; 59:10–17.
McCabe BF, McCormick KJ. Tests for autoimmune disease in otology. Am J Otol 1984; 5: 585–89.
Hughes GB, Barna BP, Kinney SE, Calabrese LH. Nalepa NL. Predictive value of laboratory tests in “autoimmune” inner ear disease: Preliminary report. Laryngoscope 1986; 96: 502–5.
Fuse T, Hayashi T, Oota N, et.al. Immunological responses in acute low-tone sensorineural hearing loss and Meniere's disease. Acta Otolaryngol 2003; 123: 26–31.
Baek MJ, Park HM, Johnson JM, Altuntas CZ, Jane-Wite D, Jaini R, Solares CA, et al. Increased frequencies of cochlin-specific T cells in patients with autoimmune sensorineural hearing loss. J Immunol 2006; 177: 4203–10.
Staecker H, Lefebvre PP. Autoimmune sensorineural hearing loss improved by tumor necrosis factor-alpha blockade: A case report. Acta Otolaryngol 2002; 122: 684–7.
Solares CA, Edling AE, Johnson JM, et.al. Murine autoimmune hearing loss mediated by CD4+ T cells specific for inner ear peptides. J Clin Invest 2004; 113: 1210–17.
Bodmer D, Brors D, Pak K, et.al. Inflammatory signals increase fas ligand expression by inner ear cells. J Neuroimmunol 2002; 129: 10–17.
Arnold W, Pfaltz CR. Critical evaluation of the immunofluorescence microscopic test for identification of serum antibodies against human inner ear tissue. Acta Otolaryngol 1987; 103: 373–78.
Boulassel MR, Deggouj N, Tomasi JP, Gersdorff M. Inner ear autoantibodies and their targets in patients with autoimmune inner ear diseases. Acta Otolaryngol 2001; 12: 28–34.
Passali D, Damiani V, Mora R, Passali FM, Passali GC, Bellussi L. P0 Antigen detection in sudden hearing loss and Meniere's disease: A new diagnostic marker? Acta Otolaryngol 2004; 124: 1145–48.
Haris JP, Sharp P. Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope 1990; 97: 63–76.
Mathews J, Rao S, Kumar BN. Autoimmune sensorineural hearing loss: Is it still a clinical diagnosis? J Laryngol Otol 2003; 117: 212–14.
Bonaguri C, Orsoni JG, Zavota L, Monica C, Russo A, Pellistri I, Rubino P, et. al. Anti-68 kDa antibodies in autoimmune sensorineural hearing loss: Are these autoantibodies really a diagnostic tool? Autoimmunity 2007; 40: 73–8.
Toubi E, Ben-David J, Kessel A, Podoshin L, Golan TD. Autoimmune aberration in sudden sensorineural hearing loss: Association with anti-cardiolipin antibodies. Lupus 1997; 6: 540–42.
Heller U, Becker EW, Zenner HP, Berg PA. Incidence and clinical relevance of antibodies to phospholipids, serotonin and ganglioside in patients with sudden deafness and progressive inner ear hearing loss. HNO 1998; 46: 583–6.
Toubi E, Ben-David J, Kessel A, Luntz M. Immune-mediated disorders associated with idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 2004; 113: 445–9.
Mouadeb, DA, Ruckenstein MJ. Antiphospolipid inner ear syndrome. Laryngoscope 2005;115: 879–83.
Loveman DM, de Comarmond C, Cepero R, Baldwin DM. Autoimmune sensorineural hearing loss: Clinical course and treatment outcome. Semin Arthritis Rheum 2004; 34: 538–43.
Zeitoun H, Beckman JG, Arts HA, Lansford CD, Lee DS, El-Kashlan HK, Telian SA, et. al. Corticosteroid response and supporting cell antibody in autoimmune hearing loss. Arch Orolaryngol Head Neck Surg 2005; 131: 665–72.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kessel, A., Toubi, E. (2008). Autoimmune Sensorineural Hearing Loss. In: Shoenfeld, Y., Cervera, R., Gershwin, M.E. (eds) Diagnostic Criteria in Autoimmune Diseases. Humana Press. https://doi.org/10.1007/978-1-60327-285-8_83
Download citation
DOI: https://doi.org/10.1007/978-1-60327-285-8_83
Publisher Name: Humana Press
Print ISBN: 978-1-60327-427-2
Online ISBN: 978-1-60327-285-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)